Morocco has “successfully” managed the response to the coronavirus by choosing “anticipation”, as the first case appeared, through strict application of quarantine, rapid acquisition of masks and respirators, and early involvement in vaccination, Spanish news agency EFE said.
Initially, the government acted quickly to protect its health system from collapse. Once this objective achieved, it focused on guaranteeing collective immunity through vaccination, wrote the agency in a story published Saturday under the title “Moroccan success: multiple vaccinations, cheap masks and border closures.”
To prevent the pandemic from getting out of hand, Morocco declared a “state of health emergency” on March 22, the same source recalled.
In parallel, the Moroccan government started, as of April 2020, simultaneous negotiations with several vaccine manufacturers to ensure its supply in an international market suffering from a serious production shortage, according to EFE.
“This effort has reduced the number of fatalities per day from a record 92 deaths on November 20, to only 4 in the last 24 hours. The case fatality rate is now 1.8/100 – while the occupancy of intensive care beds dedicated to Covid-19 has fallen from 39% to 13%,” it said.
Similarly, the daily infection rate has decreased from a peak of 6,195 cases on November 12, to 431 cases in the last 24 hours, the Spanish news agency continued.
Highlighting the measures taken by Morocco to curb the spread of the virus such as the mandatory wearing of masks, increasing mask production to 8 million units per day and selling them at low prices, EFE noted that Morocco has equipped its health centers with respirators and intensive care beds.
After the success of these steps, Morocco began its vaccination campaign on January 29. The Kingdom has already vaccinated more than 4 million people and has just added the Russian vaccine Sputnik V to those of AstraZeneca and Sinopharm, the Spanish news agency underlined.
The Kingdom has also announced the acquisition of the American vaccine Johnson & Johnson approved by the WHO, EFE concluded.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.